Arvinas
在场
高管
查看带有其 41 名主要高管的组织结构图
Arvinas 搜索最多的简介
- John Houston, President, Chief Executive Officer and Chairman of t...
- Wendy Dixon, Director
- Everett Cunningham, Director
高管在Arvinas变化
- Randy Teel 曾任 Interim Chief Financial Officer and Treasurer, 现升职为 Chief Business Officer, Interim Chief Financial Officer and Treasurer (新闻发布的2024四月25号).
- Ronald Peck, Chief Medical Officer, 已经离开公司 (新闻发布的2024三月19号).
- Noah Berkowitz已作为Chief Medical Officer加入公司 (新闻发布的2024三月19号).
创建提醒
跟踪 Arvinas 的高管变动
生物技术
Arvinas 拥有 2,290 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Delphia Therapeutics 刚刚宣布为 67 筹款数百万美元。 (公布2024五月7号).
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Arvinas 的最新新闻稿
- Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causing Proteins | Arvinas
- Arvinas to Present at the 3rd Annual Targeted Protein Degradation Summit | Arvinas
- Arvinas to Present at the Citi 15th Annual BioPharma Virtual Conference | Arvinas
- Arvinas to Present at the 2020 Wedbush PacGrow Virtual Healthcare Conference | Arvinas
- Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update | Arvinas
- Arvinas Appoints Wendy Dixon, Ph.D., to its Board of Directors | Arvinas
- Arvinas | News
- Arvinas | News
- News Releases | Arvinas
- Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform - Arvinas, Inc.
- View more press releases Close
通过电子邮件
